Nirvani Mujumdar

Nirvani Mujumdar is a highly skilled analytical chemist with extensive experience in method development and validation across various organizations within the pharmaceutical and biotech sectors. Currently serving as a Sr. Scientist in Analytical Development at Ashvattha Therapeutics, Inc., Nirvani focuses on analytical method development for drug substances and polymer-drug conjugates. Previous roles include positions at Ultragenyx, Synthego Corporation, and Emery Pharma, where Nirvani contributed to protein purification, impurity characterization, and bioanalytical method development. With a Ph.D. in Analytical Chemistry from the University of Central Florida and a strong foundation in spectroscopy and chromatography techniques, Nirvani has demonstrated expertise in supporting therapeutic studies and ensuring compliance with FDA regulations.